Mirani Sara

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2020-2025

2025

Kiss, A., Papp, V. A., Pál, A., Prokisch, J., Mirani, S., Tóth, E. B., Alshaal, T. A. A. I.: Comparative study on antioxidant capacity of diverse food matrices: applicability, suitability and inter-correlation of multiple assays to assess polyphenol and antioxidant status.
Antioxidants. 14 (3), 1-21, (article identifier: 317), 2025.

doi DEA

Journal metrics:

Q1 Biochemistry (2024)

Q2 Cell Biology (2024)

Q1 Clinical Biochemistry (2024)

D1 Food Science (2024)

Q1 Molecular Biology (2024)

Q1 Physiology (2024)

2024

Tóth, E. B., Takács, I., Kádár, K., Mirani, S., Vecsernyés, M., Lakatos, P.: Safety and Efficacy of Loading Doses of Vitamin D: recommendations for Effective Repletion.
Pharmaceuticals. 17 (12), 1-24, (article identifier: 1620), 2024.

doi DEA WoS

Journal metrics:

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

2023

Askarian, M., Movahedi, M., Motamed, N., Momeni, M., Taghrir, M. H., Mirani, S., Danaei, M.: Is Remdesivir a Good Choice for a COVID-19 Treatment in an Outpatient Setting?.
APTJ. 3 (1), 61-64, 2023.

doi DEA

Horváth, L., Mirani, S., Girgis, M. M. F., Rácz, S., Bácskay, I., Bhattoa, H. P., Tóth, E. B.: Six years' experience and trends of serum 25-hydroxy vitamin D concentration and the effect of vitamin D3 consumption on these trends.
Front. Pharmacol. 14, 1-16, (article identifier: 1232285), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmacology

Q1 Pharmacology (medical)

2020

Tóth, E. B., Mirani, S., Horváth, L., Tóth, Á., Vecsernyés, M.: Klinikai vizsgálatok értékelése az alkalmazott d-vitamin terápia az elesési- és a csonttörési kockázat tekintetében = Risk of falls and fractures associated with vitamin D therapies in scope of clinical rials.
Acta Pharm Hung. 90 (2-3), 187, 2020.

DEA